Lead: Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders

Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders  🔓 JAMA Network Open This cross-sectional study of 9,438,716 commercially insured patients examined if access to cannabis, via medical or recreational legalization, is associated with changes in the dispensing of prescription medications to treat mental health disorders. Researchers found statistically significant reductions in benzodiazepine dispensing after increases in both medical and recreational cannabis access. However, evidence suggests increases in other types of psychotropic dispensing. The study suggests that cannabis laws may be significantly associated with the population-level use of prescription drugs to treat mental health disorders, although the associations vary by drug class and state.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM